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New Ways of Working: How Non Medical Prescribing May Impact
on the Service Development of a Clozapine Clinic
Nicola Woolhouse
Abstract
The purpose of this article is to discuss the possible implications of applying non medical
prescribing practices to a Clozapine clinic in the Rotherham, Doncaster and South Humber
Mental Health NHS Foundation Trust (RDASH). To reflect on such issues the current
working practices, and the way in which non medical prescribing may be used, will be
considered, thus identifying the perceived need and evidence base for a non medical
prescribing role to improve the quality of care for service users within the Clozapine clinic.
The apparent expectations of non medical prescribing from clinic staff, colleagues and
service users will be considered including the suggested benefits, barriers to effective
working, fears, concerns and practical implications.
Key words: Clozapine Clinic, Non medical prescribing, Service development.
Introduction
Non Medical Prescribing (NMP) has developed greatly in the last 20 years; however mental
health services have only more recently begun to adopt the role for mental health nurses
(National Prescribing Centre 2005). This greater autonomy for such nurses, and change in
traditional roles, will impact on service development and ways of working and so such
changes to practice need to be clearly justified as beneficial to service users. It also needs to
be recognised that, even though changes are introduced to improve services, there may be
initial apprehension from service users as such changes to working practices occur. This
apprehension, if not appropriately managed, could become a barrier to new practices and
needs to be identified and considered to minimise any potential difficulties (Snowden 2008).
The use of non medical prescribing within a Clozapine Clinic is one specific area in which
such issues can be identified and discussed.
Current Service Provisions
Clozapine has been shown to improve service users’ quality of life and save money for the
health service by reducing the number of hospital admissions (Duggan et al 2003). The
monitoring of patients on Clozapine is a necessity due to the risks of agranulocytosis (BNF
2009). In many healthcare trusts this is done through nurse led Clozapine clinics, with initially
weekly, then fortnightly and eventually four weekly appointments for service users. Nursing
staff take blood samples, monitor physical observations, side effects and mental state
through the use of local integrated care pathways and protocols. Specialist nurses such as
those in the Clozapine clinic are well placed to advise medical colleagues regarding
prescribing issues and it is thought that such ‘de facto’ prescribing is common in such areas
(National Prescribing Centre 2005).
Clinic staff within the Rotherham service request prescription alterations as directed by the
Consultant Psychiatrist following an outpatient appointment. They may also request a
medication to reduce a side effect of Clozapine but must ask permission from the Consultant
Psychiatrist and then request a junior doctor to complete the prescription, or alternatively
refer the service user to primary care. Such prescribing practices can be argued to be time
consuming and inefficient, sometimes leading to a delay in the changes to treatment for the
service user. A further difficulty in this prescribing scenario is that clinic staff and Consultants
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are often unaware of other medications the service user receives from their General
Practitioner, as communication between primary and secondary care can be fragmented
(Lester 2006).
More recently the European Working Time Directives have limited junior doctors’ working
hours meaning that they are less available for such, arguably, inappropriate duties like the
routine monitoring of Clozapine patients (Harrison 2007). Also, the way in which Consultant
Psychiatrists work has been under review in recent years, and it is suggested that current
working practices are not in line with the ‘New Ways of Working in Mental Health’ initiative
(Department of Health 2005; Mehta et al 2007). Service users now expect more from their
health service with more time with staff to ‘participate in decision-making as equal partners’
in regards to their treatment options (Harrison 2007: 471). With such demands on current
practices it is not surprising that Clozapine clinics are identified as areas which could
particularly benefit from non medical prescribing, utilising the special expertise of the nursing
staff (National Prescribing Centre 2005). In fact Leppard (2008) identifies Clozapine clinics
as ‘an excellent example of a role for a supplementary prescriber in mental health’ (p.164).
Non Medical Prescribing in Mental Health Services
General medical services have been developing their roles in community based services
with the Cumberledge Report (1986) examining the role of district nurses and recommending
limited prescribing for district and community nurses. As the roles of community nurses
developed with the Crown Report (1989) and the introduction of the nurse prescribers
formulary (NPF) providing some autonomy for community nurses, mental health services
made their own strides to develop specialist community teams to address the needs of
service users. This included a more holistic approach and the rise of Assertive Outreach
Teams, crisis teams and early intervention teams towards the end of the century. The
National Service Framework (1999) recommended that assertive outreach should be
available for those at risk of losing contact with services and on enhanced Care Programme
Approach by April 2002. It also stipulated that ‘round the clock’ care should be available in
mental health services, thus prompting the development of the crisis team providing 24 hour
care when community teams were not available. Such progress in mental health services
has led to more autonomy for nursing staff, although with continued multi-disciplinary team
working, nurses now were given more responsibility in terms of the assessment and
management of service users within the community, and the next logical step would be for
staff to become Non Medical Prescribers.
This view is reflected nationally; the shift towards more access to services within health care
appears to be reflected in the recommendations of the Crown report (1999) which states that
prescribing rights should be extended to other nursing groups within health services.
Furthermore, the NHS Plan (2000) suggested the majority of nurses should have prescribing
rights by 2004, in some form. Mental health services prepared to adopt non medical
prescribing practices but with some caution, tending to focus on the potential of
supplementary prescribing rather than independent prescribing in mental health settings
(National Prescribing Centre 2005). Currently in RDASH non medical prescribers are
supplementary, although there is some ongoing work with a pilot scheme of independent
prescribing which may be developed in the future. Supplementary prescribing requires that:
once a diagnosis is reached and with service user’s agreement, individual evidence based
clinical management plans will be drawn up and agreed by all parties. (National Prescribing
Centre 2005: 17).
It is a voluntary partnership between independent prescriber (in this case the Psychiatrist),
supplementary prescriber (in this case the specialist nurse trained as a non medical
prescriber and to run Clozapine Clinic) and the service user. This agreement needs to be
reviewed at least annually, and the nurse must always prescribe within their competence
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(Nursing and Midwifery Council 2006), referring back to the independent prescriber if they
feel continued treatment is not within their sphere of knowledge. A clinical management plan
(CMP) must be used as a framework for supplementary prescribing, it is a legal requirement
and ensures ‘safe and effective supplementary prescribing’ (Smith & Hemingway 2005: 127).
It is also a requirement that there is shared access to service users’ records and that
prescribing documentation is kept up to date (Department of Health 2005). In preparation for
non medical prescribing in the Clozapine clinic a database of prescribing has been set up
with shared access. This way of working is in line with current developments in New Ways of
Working (Department of Health 2005) which suggest that ’traditional outpatient work’ such as
medication reviews can be taken on by specialist nurses (Harrison 2007: 473).
Identifying the Need for Change in Clozapine Clinic
According to Mehta et al (2007), Consultant Psychiatrists have huge demands on their time,
and could be better suited to dealing with emergencies and more complex cases, rather than
‘routine appointments’, instead delegating such cases to other professions. The more
effective use of time was one indicator that Clozapine clinics could benefit from the use of
supplementary prescribing.
‘It [Nurse prescribing] will work where there is a need for it. The need should
be generated by service users. Where those needs are already being met
effectively, adding more to the system may actually make things less
effective’. (Snowden 2008: 70).
The current service provision is arguably not meeting the needs of service users, medication
reviews are often delayed until seen at outpatient clinics, and then additional time is needed
to organise the prescription. There is also potential for error as prescribing decisions are
passed down to the junior doctors through Clozapine clinic staff. The use of CMPs and non
medical prescribing would put the clinic on ‘a more accountable and professional footing’
(Leppard 2008:162). Jones and Jones (2005) identify potential benefits of non medical
prescribing as ‘quicker access to healthcare and more informed patients about their
treatments’ (p.527). It is suggested that the use of non medical prescribing in Clozapine
clinics would lead to better medicines management, identifying the appropriateness of
prescriptions and reviewing them more efficiently.
There are additional issues which relate specifically to the Clozapine clinic. The
management of side effects such as hyper salivation and constipation associated with
Clozapine could be dealt with in a much timelier manner if addressed at their regular
appointment rather than waiting to see their Consultant Psychiatrist or making an additional
appointment with their GP. Some service users have displayed a reluctance to attend their
GP surgery to address such side effects, this may be due to anxiety, poor organisation skills,
or previous negative experiences of their GP (e.g. Mental Health Act assessments can be a
traumatic experience for the service user, or they may have difficulties in explaining their
needs). Care will need to be taken in regards to the budget for medication; however initiation
onto medication to manage particular side effects may increase concordance as it can
significantly impact on a service user’s lifestyle; prescribing responsibility can later be
handed back to primary care once proven an effective management strategy for that service
user. Stott and Cassells (2008) discuss the incidence of metabolic syndrome and weight
gain for service users on Clozapine and its impact on self confidence and feelings of self
worth. Such impact on daily life could be observed and acted upon, where necessary in a
Clozapine clinic:
‘Patients may also begin to appreciate nurses discussing their ADR [Adverse
Drug Reactions] and hopefully reducing the health burden and improving
medication concordance.’(Jones & Jones 2005: 530).
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It is suggested that timely assessment and intervention can reduce the negative effects of
such side effects whether it be through utilising the therapeutic relationship to offer advice,
referring service users to primary care for further assessment and treatment, or prescribing
medication in the clinic within the supplementary prescribers’ competence (Snowden 2008).
Communication could also be improved between primary and secondary care through the
use of non medical prescribing. In the development of a CMP the current medications
supplied by the General Practitioner would be listed, these were previously unknown to both
the junior doctor prescribing and the pharmacy dispensing the outpatient medication. Service
users are already routinely asked in Clozapine clinic if they have been prescribed any new
medication by their General Practitioner since their last appointment. By using a CMP the
non medical prescriber could ensure that the relevant information is passed on to both
pharmacy and the independent prescriber. Enzyme inducing drugs such as Carbamazepine
and Phenytoin can reduce plasma levels of Clozapine, and cytochrome P450 inhibitors, such
as Erythromycin, Fluoxetine and Cimetidine can increase plasma levels leading to a possible
increase in toxicity and side effects (Bell et al 1998). Such interactions could be avoided
through clearer protocols and better communication; non medical prescribing can facilitate
this by liaising with the service user and other relevant professionals to ensure more
accurate and up-to-date records.
Expectations in Implementing Non Medical Prescribing in Clozapine Clinic
The expectations for the implementation of non medical prescribing are high yet realistic. It is
known that there may be practical issues to overcome but it is thought that the overall
benefits to service users far outweigh any perceived possible difficulties.
.
It is to be expected that with such a radical change to working practices there will be some
impact on the time required to assess and document prescribing within the Clozapine clinic
setting, this certainly was the finding from the implementation of non medical prescribing in
the memory clinic in Doncaster (Smith & Hemingway 2005). It may be that more non medical
prescribers are required to deal with such a large workload, although it is hoped that the
gradual implementation (as completion of CMPs will take some time to organise) of non
medical prescribing will mean that adaptations can be made to practice to accommodate
this. It is hoped that Consultant Psychiatrists will feel able to delegate routine assessments
of service users on Clozapine to the clinic staff as they routinely see them at least every four
weeks and can refer patients back to the independent prescriber if concerned or feel
management is outside of their competence. Harrison (2007) notes a need for psychiatrists
to at least ‘be engaged in debate in the interest of our patients and of our own morale and
well-being’ in regards to embracing the increased autonomy of nurses (p.474).
It is anticipated that the service will become more efficient at addressing the service users’
needs, including faster access to medication, regular review of mental health and better
management of side effects. Through the development of a therapeutic relationship and
regular contact, the non medical prescriber would potentially be able to facilitate a better
understanding of the medication and involve the service user in the decision making
process, with opportunity to ask questions and discuss options (Luker et al 1998; DH, 2004).
This in effect may improve concordance, as service users feel they have a greater choice
with more collaboration (Brimblecombe 2005), and it is argued that faster and more efficient
management of side effects may further aid concordance as service users often cite such
effects as a reason for stopping taking medication. Leppard (2008) found that many service
users assumed she was already in the role of prescriber for Clozapine clinic, and although
there were some concerns regarding change that it did actually facilitate ‘more in-depth
discussions about their medications’ (p.162).
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A further perceived benefit of non medical prescribing in the Clozapine clinic would be to
address the issue of cigarette smoking and Clozapine serum levels. Research suggests that
smoking can have some effect on the absorption of Clozapine (Bell et al 1998). So if a
patient successfully stops smoking there is a need to measure serum levels and adjust the
dose of Clozapine as required, this currently can be delayed whilst awaiting instruction from
Consultant Psychiatrists or interpretation of Clozapine serum levels. During which time there
is a potential for service users to have reached toxic levels of Clozapine in their system since
stopping smoking, and to have increased side effects such as sedation and hyper salivation.
It is also hoped that better working relationships with General Practitioner practices in the
area would mean that they are aware of such issues and liaise with the Clozapine clinic
accordingly. With more knowledge of the service users’ medication the non medical
prescriber would hope to also decrease the number of other potential adverse drug
reactions, by having improved communication between secondary and primary care.
Potential Problems
There may be barriers to the implementation of non medical prescribing in the Clozapine
clinic, but it is hoped that an awareness of such issues will better equip the staff to deal with
them as, or if, they arise.
Firstly, is the changing role of the Clozapine clinic nurse in terms of their relationship with
both colleagues and service users. Snowden (2008) suggests that nurses express concerns:
‘That is, this role will somehow disturb a balance inherent within the (non
prescribing) therapeutic relationship between mental health nurses and their
patients’. (Snowden 2008, p68).
The move from nurse to prescriber could be suggested to be a change in the balance of
power, and non medical prescribers in Clozapine clinic will need to exercise caution that both
service users and themselves are confident and comfortable with it. There are concerns from
service users that non medical prescribers may divert nurses from focusing on core parts of
their role if devoting time to prescribing (McCann & Clark 2008; Harrison 2003). However
others see the ‘greater specialisation of nursing work’ in a more positive light and it is
acknowledged that non medical prescribers ‘can only guess as to the impact’ it may have
(Jones & Jones 2005; Snowden 2007). Non medical prescribers need to be aware of such
issues and endeavour to maintain their core skills and therapeutic relationships within mental
health nursing, whilst service users will need a reassurance that nurses will continue to be
an approachable point of contact with mental health services, and foster the process of
collaboration.
Service users will need to be fully informed of the changes and what it means to their care
package in the mental health services. Some express worries regarding nurses’ ‘knowledge
base and competence’ (National Prescribing Centre 2005: 13). If the process of non medical
prescribing is transparent, and service users are reassured by both the independent and
supplementary prescriber when completing the CMP, it is argued that such concerns will be
found to be unwarranted. However, it is suggested that ongoing education in pharmacology
and organisational support is required to facilitate good practice and reassure service users
(McCann & Clark 2008). In Rotherham there is such a psychopharmacology course run by
colleagues for South Yorkshire non medical prescribers, attendance also contributes to the
required continued professional study (National Prescribing Centre 2005), and there is also a
non medical prescribers’ forum and ongoing clinical supervision with the independent
prescriber.
There may also be inter-professional issues linked to ‘professional encroachment’ and
‘power struggles’ (Jones & Jones 2005). Initial reservations from colleagues may arise from
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a lack of knowledge about what supplementary prescribing involves and how it may impact
on their workload. Although there will be some initial organisation to set up the non medical
prescribing role in the Clozapine clinic it should eventually benefit all involved, it is hoped
that such concerns can be addressed with the support of the overall medical supervisor in
order to foster good working relationships with the other Consultants. A qualitative study has
found that psychiatrists reported an improvement in practice from introducing non medical
prescribing, which in turn made their lives easier (Jones et al 2005). There will need to be
clear protocols, and agreement between the supplementary prescriber and independent
prescriber, on when it is appropriate to refer the service user back to the independent
prescriber or on to the General Practitioner if concerns are raised outside of the
supplementary prescribers’ sphere of competence. As identified by Jones and Jones (2005),
non medical prescribers need to ‘accept that psychiatrists are experts in diagnosis and
treatment’ and recognise when such cases become more complex requiring more input from
their Consultant Psychiatrist (p.534).
At present, supplementary prescribing is suitable within the Clozapine Clinic as it fosters a
team approach to the management of service users with treatment resistant schizophrenia
with fast and efficient access to medicines. Mental health trusts have been slower than
primary care trusts in the implementation of independent prescribing in mental health
services (National Prescribing Centre 2005). However, piloting of independent prescribing in
RDASH suggests that such practices may be developed in the future for other areas such as
the Clozapine Clinic. Current legislation would mean that independent prescribing may
actually restrict necessary practices within the Clozapine clinic, as supplementary
prescribing allows for prescribing outside of the summary of product characteristics
indications when agreed in the CMP (NPC 2005). Although such practice may be a rarity
rather than the norm, it is suggested that until legislation is reformed on independent
prescribing for nurses to allow similar powers to those of medics, it is not suitable for the
Clozapine Clinic service users. It is also considered that during the initiation of non medical
prescribing within Clozapine Clinics, supplementary prescribing allows for an appropriate
level of supervision and multi-disciplinary team working in order to develop prescribing
knowledge and skills further.
Conclusion
In conclusion, there are clearly identified benefits to implementing supplementary prescribing
into the Clozapine clinic: the removal of de facto prescribing increasing the safety of
Clozapine clinic prescriptions; more in depth assessment of medications and side effects on
a more regular basis, hopefully leading to timely management of them or referral to the
appropriate care provider; more efficient access to medication and information for service
users; and a reduction of the need for Consultant psychiatrists to review patients who are
routine.
However, caution should be exercised as the impact of supplementary prescribing within the
clinic can only be estimated at this stage (Snowden 2007). It is anticipated that there may be
issues such as the increased work load of the supplementary prescriber, which may lead to
a need for more supplementary prescribers within the clinic; resistance or lack of
understanding from colleagues, possibly leading to unrealistic expectations or a reluctance
to delegate responsibility to the supplementary prescriber; and concerns from patients
regarding the relationship between them and supplementary prescriber, as well as their
perceived level of knowledge.
It is an interesting time in the development of the Clozapine clinic and, although
implementation may be complicated initially, it is hoped that once such arrangements are in
place a more efficient service will run, which will be better for service users and staff within
NWoW: How Non Medical Prescribing may Impact on the Service
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mental health services. If independent non medical prescribing is implemented within the
trust, careful consideration will be required as to how it may impact on the ability of the non
medical prescriber to offer appropriate medication under current legislation. If non medical
prescribing is successful further scope could be suggested to consider the future
development and involvement of clinic staff in other areas such as: weight management,
physical health assessment (where service users do not access primary care), and in
Lithium clinics.
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